Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
AOTI, Inc. ( (GB:AOTI) ) has issued an announcement.
AOTI, Inc., a leader in medical technology for wound healing, will present at the AJ Bell and Shares Spotlight Event in London on May 20, 2025. The presentation, led by CEO Dr. Mike Griffiths, will provide an overview of the company’s operations and innovations. This event highlights AOTI’s commitment to engaging with investors and stakeholders, potentially enhancing its market presence and investor relations.
More about AOTI, Inc.
AOTI, Inc. is a medical technology company founded in 2006, with bases in Oceanside, California, US, and Galway, Ireland. The company specializes in innovative solutions for severe and chronic wounds, focusing on reducing healthcare costs and improving patient quality of life. Its flagship product, the patented non-invasive Topical Wound Oxygen (TWO2®) therapy, has shown significant effectiveness in reducing the recurrence of Diabetic Foot Ulcers and decreasing hospitalizations and amputations. The therapy is approved by regulatory bodies in the US, Europe, UK, Canada, China, Australia, and Saudi Arabia.
Average Trading Volume: 40,792
Technical Sentiment Signal: Strong Sell
Current Market Cap: £85.09M
For detailed information about AOTI stock, go to TipRanks’ Stock Analysis page.